Patents by Inventor Michael L. Chandler

Michael L. Chandler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11966939
    Abstract: A computer device and method for processing risk related data to determine one or more insurance products for appliances and other systems located in or on an insured property. Informatic data is received from one or more informatic sensor devices relating to one or more appliances located in or on an insured property. Analysis is performed on the received informatic data to determine one or more insurance products to be recommended for at least one appliance located in or on the insured property. Notification is provided regarding determination of the one or more insurance products for the at least one appliance located in or on the insured property.
    Type: Grant
    Filed: September 3, 2021
    Date of Patent: April 23, 2024
    Assignee: United Services Automobile Association (USAA)
    Inventors: Ramsey Devereaux, Michael J. Allen, Spencer Read, David S. Franck, William M. Chandler, Daniela M. Wheeler, Kathleen L. Swain
  • Publication number: 20040198817
    Abstract: Disclosed is the use of cloprostenol and fluprostenol analogues in combination with carbonic anhydrase inhibitors for the treatment of glaucoma and ocular hypertension and ophthalmic compositions therefor.
    Type: Application
    Filed: April 20, 2004
    Publication date: October 7, 2004
    Inventors: Peter G. Klimko, John E. Bishop, Verney L. Sallee, Paul W. Zinke, George E. Barnes, Michael L. Chandler, Thomas R. Dean, Jesse A. May, Louis Desantis
  • Patent number: 6509355
    Abstract: This invention is directed to the use of glutamate antagonists to treat the disorders of outer retina.
    Type: Grant
    Filed: April 18, 2001
    Date of Patent: January 21, 2003
    Assignee: Alcon Laboratories, Inc.
    Inventors: Robert J. Collier, Jr., Mark R. Hellberg, Michael A. Kapin, George E. Barnes, Michael L. Chandler
  • Patent number: 6184250
    Abstract: Disclosed is the use of cloprostenol and fluprostenol analogues and combinations thereof with other medicaments for the treatment of glaucoma and ocular hypertension and ophthalmic compositions therefor. Also disclosed are methods of treating optic nerve disorders using the cloprostenol and fluprostenol analogues.
    Type: Grant
    Filed: March 30, 1999
    Date of Patent: February 6, 2001
    Assignee: Alcon Laboratories, Inc.
    Inventors: Peter G. Klimko, John E. Bishop, Verney L. Sallee, Paul W. Zinke, Tom R. Dean, George E. Barnes, Michael L. Chandler
  • Patent number: 4039666
    Abstract: Suppression of convulsions in warm-blooded animals is accomplished by administration of phenylsilanes of the formulas 0R.sub.2 SiX, 0RSiX.sub.2, 0SiX.sub.3, 0.sub.2 RSiX, and 0.sub.3 SiX in which R is an alkyl or alkenyl group and X is a hydroxyl group or one of several readily hydrolyzable radicals, such as the methoxy group. It should be understood that where there is more than one R or one X group in a composition, they need not be the same species.
    Type: Grant
    Filed: September 27, 1976
    Date of Patent: August 2, 1977
    Assignee: Dow Corning Corporation
    Inventors: Michael L. Chandler, Robert H. Krahnke, Robert R. LeVier